Since all these pathways are downstream of Ang II/AT1R signaling transduction (44), therapeutic strategies targeting molecules associated with Ang II signal transduction are promising to treat cardiac fibrosis and prevent HF. The gene discussed is AGT; the disease is hydrops fetalis.